Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Natalie Scholpa
Assistant Research Professor | Member of the Graduate Faculty
Pharmacology and Toxicology
Full Page
Overview
Research
More
Collaboration
(4)
Jason Wertheim
Mutual work: 2 Proposals
Collaboration Details
Hao Xin
Mutual work: 1 Proposal
Collaboration Details
Rick Schnellmann
Mutual work: 1 Proposal
Collaboration Details
Philipp Gutruf
Mutual work: 2 Proposals
Collaboration Details
Grants
(1)
Animal Purchasing and Husbandry Service Agreement in Support of Protocol 20-3190 "The Role of Epigenetics In Mitochondrial Biogenesis-mediated Recovery after Spinal Cord Injury."
Active
·
2021
·
$72.8K
·
External
Principal Investigator (PI)
animal research,
epigenetics,
mitochondrial biogenesis,
spinal cord injury,
husbandry service
Publications
(31)
Recent
Role of DNA methylation during recovery from spinal cord injury with and without β2-adrenergic receptor agonism
2023
dna methylation,
spinal cord injury,
recovery,
β2-adrenergic receptor,
agonism
FORMOTEROL AMELIORATES THERMAL HYPERALGESIA AND IMPROVES LOCOMOTOR FUNCTION AFTER MODERATE SPINAL CORD INJURY
2022
spinal cord injury,
pain management,
drug therapy,
neurological rehabilitation,
motor function
Mitochondrial biogenesis for the treatment of spinal cord injury
2022
mitochondrial biogenesis,
spinal cord injury,
treatment,
biomedical research,
neuroscience
TREATMENT WITH THE 5-HYDROXYTRYPTAMINE 1F RECEPTOR AGONIST LASMIDITAN POST-SCI UPREGULATES MITOCHONDRIAL SIRTUIN ACTIVITY
2022
neuroscience,
pharmacology,
mitochondria,
spinal cord injury,
receptor agonists
Time-to-treatment window and cross-sex potential of β2-adrenergic receptor-induced mitochondrial biogenesis-mediated recovery after spinal cord injury
2021
spinal cord injury,
mitochondrial biogenesis,
recovery,
β2-adrenergic receptor,
treatment window
FDA-approved 5-HT1F receptor agonist lasmiditan induces mitochondrial biogenesis and enhances locomotor and blood-spinal cord barrier recovery after spinal cord injury
2021
neuroscience,
spinal cord injury,
mitochondrial biogenesis,
drug development,
receptor pharmacology
ROLE OF ENDOTHELIAL CELL B2-ADRENERGIC RECEPTOR EXPRESSION ON FORMOTEROL-INDUCED RECOVERY AFTER SPINAL CORD INJURY
2021
spinal cord injury,
endothelial cells,
b2-adrenergic receptor,
formoterol,
recovery
5-hydroxytryptamine 1F receptor agonist induces mitochondrial biogenesis and promotes recovery from spinal cord injury
2020
neuroscience,
cell biology,
pharmacology,
regenerative medicine,
neurology
Formoterol, a β2-adrenoreceptor agonist, induces mitochondrial biogenesis and promotes cognitive recovery after traumatic brain injury
2020
traumatic brain injury,
beta2-adrenoreceptor agonist,
mitochondrial biogenesis,
cognitive recovery,
formoterol
Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases
2020
mitochondrial biogenesis,
therapeutic target,
neurodegenerative diseases,
traumatic cns diseases,
mitochondrial function